FDA Declares Pfizer's Osteoporosis Treatment Oporia Not Approvable

Drug Industry Daily
KEYWORDS FDA / NDA
A A

Pfizer’s highly anticipated osteoporosis treatment Oporia has been deemed “non-approvable” by the FDA, the firm announced Sept. 13.

To View This Article:

Login

Subscribe To Drug Industry Daily